InvestorsHub Logo
icon url

caltr0m

07/04/17 7:35 AM

#72998 RE: saratg #72996

Houston has become a hotbed for social entrepreneurship and grassroots tech startups of "do-gooders". Most importantly, Houston seems to be tackling real fundamental issues in our economy today - socioeconomic mobility, access to health & wellness, urban development, innovations in sanitation / public works, etc.

I wouldn't be surprised to see a quasi-lending startup come out of Texas, whose sole purpose is to fund any procedure or treatment under "Patient's Right-to-try".

If you tweak the metrics of the social finance lending model (think SoFi, LendingClub, etc.), one will see that there is enough meat on the bone to create a profitable enterprise and fill an obvious void in seeing Patient's Right-to-try come to fruition and be accessible to EVERYONE.

HAPPY 4th ALL!
icon url

MyzStreet

07/04/17 10:55 AM

#73005 RE: saratg #72996

Nice post. US FDA will get their act together or be left in the dust. Way more upside than downside here. Buy low sell high. Buy em up or just hold for the future of medicine. This is the infancy stages. See the big picture! Patience will make money here.

https://singularityhub.com/2017/01/17/stem-cells-are-poised-to-change-health-and-medicine-forever/